Ketone Body β Hydroxybutyrate Ameliorates Colitis By Promoting M2 Macrophage Polarization Through The STAT6 Dependent Signaling Pathway

This study investigated whether beta-hydroxybutyrate (BHB), a ketone body produced during fasting or ketogenic diets, could help treat inflammatory bowel disease (IBD). Researchers first examined tissue samples from IBD patients and found they had significantly lower levels of BHB in their intestinal lining compared to healthy people, and these low levels correlated with more severe disease.

The scientists then tested BHB treatment in mice with chemically-induced colitis (intestinal inflammation similar to IBD). Mice given BHB supplements showed remarkable improvements: they lost less weight, had less colon shortening, reduced disease severity scores, and better tissue healing compared to untreated mice. The protective effects appeared to work by influencing immune cells called macrophages.

Macrophages can exist in two main states: M1 (pro-inflammatory, like firefighters responding to an emergency) and M2 (anti-inflammatory and healing-focused, like repair crews). The research showed that BHB specifically promotes the M2 healing state through a cellular pathway called STAT6. When BHB was present, macrophages switched from causing inflammation to promoting tissue repair and producing anti-inflammatory molecules. This led to better intestinal barrier function and faster healing of damaged tissue.

This research suggests that ketones may offer a natural way to support gut health and manage inflammatory conditions. For patients interested in metabolic health, this adds to growing evidence that ketogenic diets or intermittent fasting might benefit digestive wellness beyond just weight management, though more human studies are needed before clinical recommendations can be made.